Jakob Loven

Jakob Loven, PhD, is a seasoned professional with extensive experience in the biotechnology and healthcare sectors. As Managing Partner at Nextech Invest Ltd. since August 2017, Loven also holds influential board positions at multiple organizations, including IDRx, Hexagon Bio, Flare Therapeutics, Boundless Bio, IconOVir Bio, and Arrakis Therapeutics. Loven is actively involved in advisory roles, such as with Breakthrough Properties. Loven's academic background includes a Doctor of Philosophy (Ph.D.) in Medical Sciences from Karolinska Institutet and a Bachelor's degree in Biomedical Sciences from Anglia Ruskin University. Additionally, Loven completed an International Baccalaureate in Natural Sciences at Sigtunaskolan Humanistiska Läroverket.